Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema.

Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema. Abstract Text:

Christian Lohrmann,Etelka Foeldi,Jean-Paul ,Mathias Langer,Christian Lohrmann,Etelka Foeldi,Jean-Paul ,Mathias Langer,Christian Lohrmann,Etelka Foeldi,Jean-Paul ,Mathias Langer,

BACKGROUND: To assess the feasibility of interstitial magnetic resonance lymphangiography with intracutaneous injection of a commercially available, non-ionic, extracellular paramagnetic contrast agent, to visualize lymphatic vessels in patients with clinically advanced stages of primary lymphedema. METHODS: Sixteen lower extremities in 8 patients with clinically advanced stages of primary lymphedema were examined with magnetic resonance lymphangiography. A 18 mL of gadodiamide and 2 mL of mepivacainhydrochloride 1% were subdivided into 10 portions and injected intracutaneously into the dorsal aspect of both feet. For MRL, a 3D spoiled gradient-echo sequence (Volumetric Interpolated Breathold Examination, VIBE) was performed. RESULTS: The beaded appearance of lymphatic vessels extending from the injection site was detected in all 16 lower extremities (100%). In 10 lower extremities (63%), lymphatic vessels of the upper leg could be visualized. A contrast enhancement was observed in 10/16 inguinal lymph node groups (63%). In 12 lower extremities (75%) collateral vessels with dermal back-flow areas between lymphatic vessels were seen. CONCLUSION: Magnetic resonance lymphangiography is safe, technically feasible, and assists the clinician in the therapeutic planning of patients with clinically advanced stages of primary lymphedema by imaging the pathologically modified lymphatic vessels and accompanying complications non-invasively.

Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema. Publishing Authors By Initials

C Lohrmann,E Foeldi,JP ,M Langer,C Lohrmann,E Foeldi,JP ,M Langer,C Lohrmann,E Foeldi,JP ,M Langer,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Acta tropica

VOLUME: 104

Page Numbers: 8-15

Journal Abbreviation: Acta Trop.

ISSN: 0001-706X

DAY: 12

MONTH: 07

YEAR: 2007

Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370374

Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema.

AFFILIATION: Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55, D-79106 Freiburg, Germany. christian.lohrmann@uniklinik-freiburg.de

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Trop

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema Related Publications

• 318.
• A microfabricated scaffold for retinal progenitor cell grafting.
• A porous photocurable elastomer for cell encapsulation and culture.
• Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells.
• Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates.
• Dexrazoxane for anthracycline extravasation.
• Dual-channel two-photon microscopy study of transdermal transport in skin treated with low-frequency ultrasound and a chemical enhancer.
• Effects of growth factors on extracellular matrix production by vocal fold fibroblasts in 3-dimensional culture.
• Evaluation of the porosity, the tortuosity, and the hindrance factor for the transdermal delivery of hydrophilic permeants in the context of the aqueous pore pathway hypothesis using dual-radiolabeled permeability experiments.
• First-principles, structure-based transdermal transport model to evaluate lipid partition and diffusion coefficients of hydrophobic permeants solely from stratum corneum permeation experiments.
• Gastric necrosis complicating lately a Nissen fundoplication : Report of a case.
• Interplay of biomaterials and micro-scale technologies for advancing biomedical applications.
• Interstitial MR lymphangiography - a diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema.
• Intoxication-related fatalities in northern Germany.
• Introduction and Overview: 475: 9:00 AM-9:05 AM.
• MRI and (18)FDG-PET in the assessment of bone marrow infiltration of the spine in cancer patients.
• Mechanism, Classification, Pertinent Anatomy: 477: 9:25 AM-9:45 AM.
• Microengineered hydrogels for tissue engineering.
• Minimally invasive surgery for pancreatic endocrine tumours.
• Peripheral metabolism of (R)-[(11)C]verapamil in epilepsy patients.
• Prednisone in the induction of ovulation.
• Synthesis and characterization of photocurable elastomers from poly(glycerol-co-sebacate).
• Synthesis of poly(beta-amino ester)s with thiol-reactive side chains for DNA delivery.
• Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons.
• The effect of actin disrupting agents on contact guidance of human embryonic stem cells.
• Therapeutic use of release-modifying drugs.
• Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo.
• [Indications for radiotherapy of female sterility and menstruation disorders.]
• [Preoperative staging of rectal cancer]
• [Type D personality, coping with stress and intensity of PTSD symptoms in firefighters]